verified SJR 1,881 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Academic Press Inc.

workspace_premium Q1 — Obstetrics and Gynecology lock Subscription Unclaimed

Gynecologic Oncology

Gynecologic Oncology is a journal indexed in SJR in Obstetrics and Gynecology and Oncology with an H index of 192. It has an SJR impact factor of 1,881 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,881.

Gynecologic Oncology focuses its scope in these topics and keywords: cancer, ovarian, cervical, gynecologic, cell, recurrent, brca, patients, poor, serous, ...

ISSN: 0090-8258

Editorial: Academic Press Inc.

Category: Obstetrics and Gynecology

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

1,881 Q1

H-index 192

Tasa de Aceptación pie_chart

20% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

NPD Subscription

Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

1,881

H-index

192

Docs (year)

362

Docs 3y

1102

Total refs

11751

Cites 3y

4599

Citable 3y

1041

Cites/Doc 2y

3.67

Ref/Doc

32.46

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapy

Variation of small bowel sparing with small bowel displacement system according to the physiological status of the bladder during radiotherapy for cervical cancer

Disparities in care among patients with low-grade serous ovarian carcinoma

Diagnosis and management of growing teratoma syndrome after ovarian immature teratoma: A single center experience

Development and Assessment of a General Theory of Cervical Carcinogenesis Utilizing a Severe Combined Immunodeficiency Murine-Human Xenograft Model

Cystadenocarcinoma of the abdominal wall following caesarean section: case report and review of the literature

Conservative surgery for borderline ovarian tumors: A review

Comparative study of laparoscopico-vaginal radical hysterectomy and abdominal radical hysterectomy in patients with early cervical cancer

Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus

Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix

Clinical trial methodology in rare gynecologic tumor research: Strategies for success

Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women

SHOW MORE ARTICLES

Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue

A 104-year-old woman with advanced cervical carcinoma of the uterus

BARD1, a possible biomarker for breast and ovarian cancer

Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

Apoptosis May Be an Early Event of Progestin Therapy for Endometrial Hyperplasia

An integrated molecular profile of endometrioid ovarian cancer

An analysis of 84,244 patients from the British Columbia cytology-colposcopy program

Allelic Losses at Chromosome 3p Are Seen in Human Papilloma Virus 16 Associated Transitional Cell Carcinoma of the Cervix

Accelerating gastrointestinal recovery in women undergoing ovarian cancer debulking: A randomized, double-blind, placebo-controlled trial

A Prospective Controlled Trial of Early Postoperative Oral Intake Following Major Abdominal Gynecologic Surgery

A prospective algorithm to reduce anastomotic leaks after rectosigmoid resection for gynecologic malignancies

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.